贏合科技(300457.SZ):2023年度擬向銀行申請綜合授信額度合計130億元
格隆匯3月28日丨贏合科技(300457.SZ)公佈,為滿足公司生產經營和發展需要,保證公司及子公司經營活動中融資業務的正常開展,簡化審批手續,公司及合併報表範圍內的子公司2023年度擬向銀行申請綜合授信額度合計130億元人民幣,以上授信額度最終以各家銀行實際審批的結果為準,具體融資金額將根據公司及子公司運營資金的實際需求確定。
此次綜合授信額度有效期限自公司2022年度股東大會審議通過之日起至公司2023年年度股東大會召開之日止。借款利率參照中國人民銀行規定的利率,由公司及子公司與借款銀行協商確定,並授權公司法定代表人在銀行綜合授信額度總額範圍內根據資金需求負責與銀行簽署相關協議及文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.